207

Samsung Biologics

Stock
Stock
ISIN: KR7207940008
Ticker: 207940
KR7207940008
207940

Price

Price

CHART BY

Information

SAMSUNG BIOLOGICS Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services for pharmaceutical products. It operates through the CDMO and Biopharmaceutical Development and Commercialization business divisions. The CDMO division provides development services from cell line development to early clinical trials, including cell line development, processes, formulations, and analysis methods. The Biopharmaceutical Development and Commercialization division focuses on the development and commercialization of biosimilars and is conducting research and development on various disease fields such as autoimmune diseases, cancer diseases, ophthalmic diseases, and blood diseases. The company was founded on April 22, 2011 and is headquartered in Incheon, South Korea.

Industries
Biotechnology
Sector
Health Care

Identifier

ISIN
KR7207940008
Primary Ticker
207940

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation